Literature DB >> 12386282

Contribution of genetically engineered animals to the analyses of complement in the pathogenesis of nephritis.

Norio Hanafusa1, Hajime Sogabe, Koei Yamada, Takehiko Wada, Toshiro Fujita, Masaomi Nangaku.   

Abstract

The complement system is indispensable for host defence. Unregulated activation, however, is related to various diseases. In order to elucidate the significance of complement, methodology that disrupts the complement system is essential. Advances in molecular genetics made direct modulations of the genes of complement components and their regulatory proteins feasible. One method is disruption of genes that encode complement components. Several studies have been conducted with these mice in models such as nephrotoxic serum (NTS) nephritis, ischaemia reperfusion and immune complex-mediated glomerulonephritis. These studies all showed that depletion of complement components ameliorated the severity of the diseases. Complement regulatory protein serves a regulatory role in the complement system. Genetically engineered animals that overexpress these proteins have been employed to elucidate their biological roles. Mice overexpressing soluble complement regulatory proteins were protected from the lesion of both NTS and the glomerular endothelial injury model. In contrast, knockout mice that lack expression of decay-accelerating factor (DAF), a complement regulatory protein, developed severe glomerular lesions when subnephritogenic doses of NTS were administered. These genetically engineered animals shed light on the mechanism of initiation and progression of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386282     DOI: 10.1093/ndt/17.suppl_9.34

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

Review 2.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

3.  NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease.

Authors:  Hong Lian; Li Yang; Allysa Cole; Lu Sun; Angie C-A Chiang; Stephanie W Fowler; David J Shim; Jennifer Rodriguez-Rivera; Giulio Taglialatela; Joanna L Jankowsky; Hui-Chen Lu; Hui Zheng
Journal:  Neuron       Date:  2014-12-18       Impact factor: 17.173

4.  Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.

Authors:  Yuxuan Zhen; Stephen O Priest; Wen-Hai Shao
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

5.  The Expression Profile of Complement Components in Podocytes.

Authors:  Xuejuan Li; Fangrui Ding; Xiaoyan Zhang; Baihong Li; Jie Ding
Journal:  Int J Mol Sci       Date:  2016-03-30       Impact factor: 5.923

6.  Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis.

Authors:  Chia-Yu Lin; Jen-Ai Lee; Po-Yeh Lin; Shih-Chun Hua; Pei-Yun Tsai; Bi-Li Chen; Chia-En Lin; Tzong-Huei Lee; Shih-Ming Chen
Journal:  PLoS One       Date:  2020-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.